Why am I not losing weight on semaglutide?

There is a particular kind of quiet that arrives in month three or four on semaglutide. The first transformation has happened. Clothes fit differently. Food noise is softer. The scale, however, has stopped moving. Two weeks pass. Then four. The dose is the same. The plate is the same. Nothing has obviously changed — except the number, which now refuses to.

Most people, faced with this silence, do one of two things. They panic and start cutting calories aggressively, which usually backfires. Or they decide the medication has stopped working, which is almost never true. The honest answer sits somewhere in the middle and is far less dramatic than either reaction.

The quick answer

Plateaus are normal — even on the most effective dose

Clinical trials of semaglutide and tirzepatide show smooth, beautiful average weight-loss curves. The individual curves underneath those averages do not look smooth at all. They zigzag. They stall for weeks. They drop suddenly. They sometimes drift up for a fortnight before resuming a downward trend. The averaging hides this. Real-world experience does not.

A two-to-six-week plateau at any point on a GLP-1 medication is a normal, expected event. Many people experience three or four of them in a single year. They are part of how the body adjusts — not a signal that the drug has lost effect, not a sign that you've broken something.

Are you actually on an effective dose yet?

The most common explanation for not losing weight on semaglutide is also the simplest: you haven't reached the dose that does most of the work. Wegovy titrates from 0.25 mg through 0.5 mg, 1 mg, 1.7 mg, and lands at 2.4 mg. Ozempic, used off-label for weight loss, typically tops out at 2 mg. The early doses exist to build tolerance — they are not designed to produce major weight loss.

Most of the meaningful loss in the trials happened at the highest doses, sustained for months. If you are still titrating, or if you are stuck at 1 mg because side effects made the next step uncomfortable, the plateau may simply be the dose you're on. That's worth a conversation with your prescriber — not necessarily to rush the titration, but to make sure the current dose is the right one for your goals and your body.

Protein is almost always the second answer

When appetite drops on semaglutide, total food intake usually drops faster than people expect. Protein drops with it — often disproportionately, because protein-dense foods take more chewing, more cooking, and more interest in food than the medication tends to leave you with. A bowl of soup is easy. A grilled chicken breast is not.

Low protein intake quietly stalls weight loss in two ways. It accelerates lean mass loss, which lowers resting metabolic rate — so the same calories that produced a deficit two months ago no longer do. And it leaves you less satiated between meals, which makes the small extra snack feel necessary. Both effects compound. Both are reversible.

A reasonable working target on a GLP-1 medication is roughly 0.7–1 g of protein per pound of goal body weight, spread across three to four meals. If that sounds like a lot when nothing appeals, that's because it is. It is also the single change most likely to break a plateau without dropping calories further.

Why protein suddenly matters so much on GLP-1 medications →

The scale isn't always reading fat

Daily body weight fluctuates by one to four pounds for reasons that have nothing to do with fat. Sodium from a slightly different meal. Carbohydrate stored as glycogen with its accompanying water. Hormonal cycle. A new strength session that left muscle tissue inflamed and holding fluid. A long flight. A bad night of sleep. A particularly stressful week.

Most plateaus that worry people are actually three or four of these factors stacked. The fat loss didn't stop — the scale just stopped showing it, because water came in faster than fat came off. A trend line over four to eight weeks tells a more honest story than any single morning weigh-in. The honest weeks include the disappointing ones.

Sleep is metabolic, not just restorative

Short or fragmented sleep raises cortisol, lowers leptin, and increases hunger hormones the next day. It also nudges the body to hold water and slows recovery from training. Two consecutive weeks of six-hour nights can be the entire explanation for a plateau that otherwise looks unexplained.

Sleep is one of the few interventions where the marginal return is large and the cost is almost nothing. If you are stalled and sleeping poorly, sleep is the lever before food, before training, before adjusting dose. The medication amplifies what the rest of life is doing. Tired bodies hold weight.

You may be carrying days of unmoved digestion

Constipation is one of the most under-discussed plateau causes on GLP-1 medications. Slowed gastric emptying, lower food volume, and reduced thirst combine to slow the entire digestive system. The result is sometimes several pounds of perfectly normal digestive contents the scale is reading as 'no progress this week.'

If bowel movements have become infrequent, the fix is usually some combination of more water, magnesium citrate in the evening (with your prescriber's okay), soluble fiber from oats, chia, or psyllium, and daily walking. The plateau often resolves itself within days once digestion catches up.

Constipation on Mounjaro and other GLP-1 medications, explained →

Stress and the hormonal floor

Stress acts on weight in two directions. Acute stress often suppresses appetite. Chronic stress does the opposite — sustained cortisol elevation increases water retention, encourages central fat storage, and makes the body protective of its current weight. A bad month at work can pause weight loss for that whole month, even if everything else looks the same on paper.

Hormonal cycles add another layer. Many women on semaglutide notice a one-to-three-pound rise in the days before menstruation that fully resolves within a week. PCOS, thyroid changes, perimenopause, and hormonal contraception all shift the baseline. None of these are reasons to stop the medication. They are reasons to expand the time window you judge progress over.

Dose timing, splitting, and consistency

Weekly injections are designed to maintain a steady serum level. Drifting injection day by several days each week — Wednesday one week, Saturday the next, Tuesday the week after — can produce real swings in how the medication feels and how appetite tracks. A consistent injection day, week after week, tends to produce a more predictable response.

Some people also find their plateau breaks when they move their injection from morning to evening, or vice versa. The pharmacology doesn't change much, but the rhythm of side effects and appetite does. If something has stalled for more than six weeks at a stable dose, this is one of the cheaper experiments to run.

Intake creep — the quiet, invisible kind

After a few months on a GLP-1, the brain adjusts. The medication still works, but the conscious sense of being 'not hungry' fades into background. Portions creep up a little. The small snack returns. The handful of nuts becomes two. None of it feels like overeating. Over a week, it can easily add several hundred calories a day.

This is not a willpower failure. It is the normal arc of adapting to any appetite-suppressing intervention, and it is the single most common explanation for stalls after month four. A short tracking experiment — three honest days, every bite logged — almost always finds the missing calories within an hour of effort. The goal isn't to track forever. It's to recalibrate the perception of 'normal portions.'

If you've lost weight but not improved, you may have lost lean mass

Without resistance training, between a quarter and forty percent of total weight lost on a GLP-1 medication can be lean tissue. That loss lowers resting metabolic rate, which makes future loss harder and weight regain easier. The scale may read 'success.' Body composition often tells a different story.

Two or three short, full-body strength sessions a week is enough to preserve most lean mass for most people. Combined with adequate protein, it changes the shape of the weight loss — and often unlocks plateaus that pure calorie cutting cannot.

GLP-1 medications and muscle loss: how worried should you be? →

The expectation problem

Some plateaus are not plateaus at all. They are losses smaller than the rate you secretly hoped for. The trials suggest an average of roughly fifteen percent total body weight at one year on top doses of semaglutide. Many people lose more. Many lose less. The internet, lined with the most dramatic transformations, has reset expectations to a place real biology rarely reaches in a calendar quarter.

Half a pound a week, sustained for a year, is twenty-six pounds. That is a meaningful, body-changing amount of weight. It also looks, from inside the week, like almost nothing. The plateau you're frustrated with may be a normal pace you've talked yourself out of recognising.

The scale is a single number. The journey is everything around it — appetite, sleep, mood, strength, clothes, energy, food noise. Judge the medication by the whole story, not by the loudest data point.

What actually helps — in order

If you're stalled, this is the rough order worth trying before assuming anything has gone wrong.

1. Hold steady for two more weeks. Most plateaus end on their own without any intervention. Reacting too fast often creates new problems.
2. Take an honest three-day food log. Look at protein in particular. If you're under 0.7 g per pound of goal body weight, that is almost certainly the lever.
3. Add one more litre of water per day and check sleep. Both are free, both are quietly metabolic.
4. Audit your weekly resistance training. If you do none, start with two short sessions. If you do some, add a little intensity, not volume.
5. Re-stabilise your injection day. Same day, same general time, for four weeks.
6. If the plateau survives all of that for six to eight weeks at your current dose, that is a real conversation with your prescriber — not a failure of the medication, but information about whether the dose still fits the goal.

What rarely helps

The instinct in a plateau is to do something dramatic. The plateau-breakers people reach for first are usually the ones that backfire most reliably.

• Cutting calories aggressively. This accelerates muscle loss and often produces a rebound when normal eating resumes.
• Adding hours of cardio. Cardio supports cardiovascular health but rarely breaks a stall and can deepen the fatigue many people already feel.
• Switching medications impulsively. Different drugs have different side-effect profiles and titration curves; the change itself is rarely the variable that mattered.
• Skipping doses. This produces a temporary rebound of appetite that almost always leads to a worse stall.
• Daily weigh-ins read in isolation. They are the fastest way to convince yourself nothing is working when, on a four-week trend line, plenty is.

Tracking the real trend, gently

Plateaus feel different when you can see the longer line they sit inside. A weekly average weight, charted across three or four months, makes most plateaus look like exactly what they are — small flat sections inside a much longer descent. Without that view, every flat week feels final.

Some readers find it helpful to track weight trend, protein, hydration, sleep, and appetite in a single quiet place. Tools like Skinny Wingman are built for that — not to optimise anything aggressively, just to make the patterns legible. Others keep a notebook. The platform matters less than the perspective.

How to track your GLP-1 journey beyond the scale →

When the plateau is worth a real conversation

Some plateaus do deserve clinical attention. If you've been at your top tolerated dose for three months and there's been no movement in weight, measurements, or appetite — and protein, sleep, and stress are all reasonable — that's worth raising with your prescriber. Thyroid, adrenal, and other endocrine issues are uncommon but real, and they can present exactly this way.

It's also worth a conversation if the plateau has stopped feeling like a plateau and started feeling like everything is moving in reverse — appetite back, energy down, weight rising at a stable dose. That pattern is rare on a working dose of semaglutide and is the kind of thing a prescriber should hear about, not the internet.

The takeaway

Most semaglutide plateaus are not failures. They are the body adjusting, the dose still climbing, the food slipping slightly higher than it feels, the water and sleep and stress and cycle quietly doing their work in the background. The medication has not stopped working. The curve has just gone briefly flat, the way curves do.

The temptation, when the scale stops, is to do more. The honest answer is usually to do less, more carefully — and to give the body the four-to-eight-week window it almost always needs to start moving again. Most plateaus end the same way they started: quietly, without warning, on a morning that looked exactly like every other morning that month.